Assignment of Assignor's Interest

Recorded: 2025-06-04 Pages: 5

Assignor

Executed: 2020-10-11

Assignee

NOVARTIS AG

LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND

Covered Property (1)

CD19 and CD22 Chimeric Antigen Receptors and Uses Thereof

Application: 19/215,827 →

Publication: US 2026/0042812

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.